112 related articles for article (PubMed ID: 1903028)
21. [Therapeutic experience of childhood stage III neuroblastoma].
Ye QD; Tang JY; Pan C; Chen J; Xue HL; Chen J; Dong L; Zhou M; Shen SH
Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(22):1556-8. PubMed ID: 20973238
[TBL] [Abstract][Full Text] [Related]
22. [N-myc gene copies in children with neuroblastoma and its clinical significance].
Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
[TBL] [Abstract][Full Text] [Related]
23. Neuroblastoma in adolescents.
Gaspar N; Hartmann O; Munzer C; Bergeron C; Millot F; Cousin-Lafay L; Babin-Boilletot A; Blouin P; Pajot C; Coze C
Cancer; 2003 Jul; 98(2):349-55. PubMed ID: 12872356
[TBL] [Abstract][Full Text] [Related]
24. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
25. Neuroblastoma sympathicum.
Koutecký J
Acta Univ Carol Med Monogr; 1984; 106():1-133. PubMed ID: 6391118
[No Abstract] [Full Text] [Related]
26. Long-term follow-up of children with neuroblastoma receiving radiotherapy to metastatic lesions within the German Neuroblastoma Trials NB97 and NB 2004.
Jazmati D; Butzer S; Hero B; Doyen J; Ahmad Khalil D; Steinmeier T; Schulze Schleithoff S; Eggert A; Simon T; Timmermann B
Strahlenther Onkol; 2021 Aug; 197(8):683-689. PubMed ID: 33300099
[TBL] [Abstract][Full Text] [Related]
27. Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979-2015.
Berthold F; Spix C; Kaatsch P; Lampert F
Paediatr Drugs; 2017 Dec; 19(6):577-593. PubMed ID: 28786082
[TBL] [Abstract][Full Text] [Related]
28. [Neuroblastoma at the Giannina Gaslini Institute. Analysis of 94 cases diagnosed 1972-1981].
De Bernardi B; Garaventa A; Bartolini M; Rizzo A; Rosanda C; Bisogni C; Melodia A; Magnaguagno G; Ricci G; Lamedica G
Pediatr Med Chir; 1983; 5(1-2):49-58. PubMed ID: 6634442
[TBL] [Abstract][Full Text] [Related]
29. Bilateral adrenal neuroblastoma.
Ishiguro Y; Iio K; Seo T; Nagaya M; Ito T
Eur J Pediatr Surg; 1994 Feb; 4(1):37-9. PubMed ID: 8199131
[TBL] [Abstract][Full Text] [Related]
30. Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: interim results.
Schilling FH; Berthold F; Erttmann R; Michaelis J; Spix C; Sander J; Schwarz K; Treuner J
Med Pediatr Oncol; 2000 Dec; 35(6):701-4. PubMed ID: 11107150
[TBL] [Abstract][Full Text] [Related]
31. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
[TBL] [Abstract][Full Text] [Related]
32. [Neuroblastoma Early Detection Model Project. Background and results].
Schilling FH
Kinderkrankenschwester; 2002 Jul; 21(7):295-6. PubMed ID: 14606374
[No Abstract] [Full Text] [Related]
33. Screening of infants and mortality due to neuroblastoma.
Woods WG; Gao RN; Shuster JJ; Robison LL; Bernstein M; Weitzman S; Bunin G; Levy I; Brossard J; Dougherty G; Tuchman M; Lemieux B
N Engl J Med; 2002 Apr; 346(14):1041-6. PubMed ID: 11932470
[TBL] [Abstract][Full Text] [Related]
34. Neuroblastoma: outcome over a 14 year period from a tertiary care referral centre in India.
Agarwala S; Mandelia A; Bakhshi S; Srinivas M; Bajpai M; Gupta AK; Gupta DK; Bhatnagar V
J Pediatr Surg; 2014 Aug; 49(8):1280-5. PubMed ID: 25092090
[TBL] [Abstract][Full Text] [Related]
35. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
[TBL] [Abstract][Full Text] [Related]
36. [Economic evaluation of screening for neuroblastoma].
Lacour A; Chauvin F; Duru G; Philip T
Rev Epidemiol Sante Publique; 1994; 42(1):24-33. PubMed ID: 8134663
[TBL] [Abstract][Full Text] [Related]
37. Multivariate evaluation of prognostic factors in localized neuroblastoma.
Berthold F; Kassenböhmer R; Zieschang J
Am J Pediatr Hematol Oncol; 1994 May; 16(2):107-15. PubMed ID: 8166363
[TBL] [Abstract][Full Text] [Related]
38. Persistence and possible progression of a pelvic neuroblastoma detected by mass screening during 19 months.
Bernstein ML; Azouz EM; Woods W; Tuchman M; Renaud L; Lemieux B
Am J Pediatr Hematol Oncol; 1994 May; 16(2):164-6. PubMed ID: 8166370
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of neuroblastoma: analysis of a single institution.
Izbicki T; Mazur J; Izbicka E
Anticancer Res; 2003; 23(2C):1933-8. PubMed ID: 12820482
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
